This medication is formulated with two types of insulin namely Insulin Degludec a longacting insulin and Insulin Aspart a rapidacting insulin Its primary purpose is to effectively manage and regulate blood sugar levels in individuals with diabetes By combining these two insulins it provides a consistent and lasting effect through Degludec while Aspart works swiftly to control blood sugar levels following meals This synergistic combination ensures stable glucose levels throughout the day It is important to follow the prescribed dosage and duration of use as directed by your healthcare provider

medwiki-image-d

More medicines by Novo Nordisk India Pvt Ltd

Lentard 40IU/ml Injection
LENTARD 40IU/ML INJECTION

Insulin Isophane/NPH (40IU)

Human Zinulin 40IU/ml Injection
HUMAN ZINULIN 40IU/ML INJECTION

Insulin Isophane/NPH (40IU)

Insulatard SC 40IU Injection
INSULATARD SC 40IU INJECTION

Insulin Isophane/NPH (40IU)

Human Actrapid 40IU/ml Solution for Injection
HUMAN ACTRAPID 40IU/ML SOLUTION FOR INJECTION

Human Insulin/Soluble Insulin (40IU)

Insulin (Nnd) 40IU/ml Injection
INSULIN (NND) 40IU/ML INJECTION

Human Insulin/Soluble Insulin (40IU)

Available in 2 variations

Ryzodeg 100IU/ml Penfill 3ml

Ryzodeg 100IU/ml Penfill 3ml

Ryzodeg 100IU/ml Flextouch

Ryzodeg 100IU/ml Flextouch

Insulin Degludec (2.56mg) + Insulin Aspart (1.05mg)

pre-filled pen of 3 ml solution for injection

Written By:

about-us.jpg

Published At: Dec 11, 2024

Updated At: Jan 28, 2025

Reviewed By:

about-us.jpg

Published At: Dec 11, 2024

Updated At: Jan 28, 2025

Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.

ryzodeg

Prescription Required

Composition :

insulin degludec + insulin aspart

MRP :

₹1239 - ₹1450